{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T07:16:50Z","timestamp":1775200610695,"version":"3.50.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00467-025-06721-5","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T09:32:18Z","timestamp":1740994338000},"page":"2691-2702","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Management dilemma of anti-GBM disease and p-ANCA-associated vasculitis with necrotizing skin lesions in a pediatric patient"],"prefix":"10.1007","volume":"40","author":[{"given":"Valeria","family":"Chirico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Silipigni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Tripodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Conti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Immacolata","family":"Rulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Granata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Cinquegrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eloisa","family":"Gitto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9143-4637","authenticated-orcid":false,"given":"Roberto","family":"Chimenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"6721_CR1","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.2215\/CJN.01380217","volume":"12","author":"SP McAdoo","year":"2017","unstructured":"McAdoo SP, Pusey CD (2017) Anti-glomerular basement membrane disease. Clin J Am Soc Nephrol 12:1162\u20131172","journal-title":"Clin J Am Soc Nephrol"},{"key":"6721_CR2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jaut.2014.01.024","volume":"48\u201349","author":"T Hellmark","year":"2014","unstructured":"Hellmark T, Segelmark M (2014) Diagnosis and classification of Goodpasture\u2019s disease (anti-GBM). J Autoimmun 48\u201349:108\u2013112","journal-title":"J Autoimmun"},{"key":"6721_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fped.2020.00205","volume":"8","author":"A Mastrangelo","year":"2020","unstructured":"Mastrangelo A, Serafinelli J, Giani M, Montini G (2020) Clinical and pathophysiological insights into immunological mediated glomerular diseases in childhood. Front Pediatr 8:205","journal-title":"Front Pediatr"},{"key":"6721_CR4","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1093\/ndt\/gfu399","volume":"30","author":"B Alchi","year":"2015","unstructured":"Alchi B, Griffiths M, Sivalingam M, Jayne D, Farrington K (2015) Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort. Nephrol Dial Transplant 30:821\u2013828","journal-title":"Nephrol Dial Transplant"},{"key":"6721_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jaut.2008.04.005","volume":"31","author":"JD Ooi","year":"2008","unstructured":"Ooi JD, Holdsworth SR, Kitching AR (2008) Advances in the pathogenesis of Goodpasture\u2019s disease: from epitopes to autoantibodies to effector T cells. J Autoimmun 31:295\u2013300","journal-title":"J Autoimmun"},{"key":"6721_CR6","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.3390\/biomedicines11112978","volume":"11","author":"C Gluhovschi","year":"2023","unstructured":"Gluhovschi C, Gadalean F, Velciov S, Nistor M, Petrica L (2023) Three diseases mediated by different immunopathologic mechanisms\u2014ANCA-associated vasculitis, anti-glomerular basement membrane disease, and immune complex-mediated glomerulonephritis\u2014a common clinical and histopathologic picture: rapidly progressive crescentic glomerulonephritis. Biomedicines 11:2978","journal-title":"Biomedicines"},{"key":"6721_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2215\/CJN.04290417","volume":"13","author":"EE van Daalen","year":"2018","unstructured":"van Daalen EE, Jennette JC, McAdoo SP, Pusey CD, Alba MA, Poulton CJ, Wolterbeek R, Nguyen TQ, Goldschmeding R, Alchi B, Griffiths M, de Zoysa JR, Vincent B, Bruijn JA, Bajema IM (2018) Predicting outcome in patients with anti-GBM glomerulonephritis. Clin J Am Soc Nephrol 13:63\u201372","journal-title":"Clin J Am Soc Nephrol"},{"key":"6721_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/MD.0b013e31822f6f68","volume":"90","author":"Z Cui","year":"2011","unstructured":"Cui Z, Zhao J, Jia XY, Zhu SN, Jin QZ, Cheng XY, Zhao MH (2011) Anti-glomerular basement membrane disease outcomes of different therapeutic regimens in a large single-center Chinese cohort study. Medicine 90:303\u2013311","journal-title":"Medicine"},{"key":"6721_CR9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1309\/NPTP4UKV7JU3ELMQ","volume":"125","author":"EG Fischer","year":"2006","unstructured":"Fischer EG, Lager DJ (2006) Anti-glomerular basement membrane glomerulonephritis: a morphologic study of 80 cases. Am J Clin Pathol 125:445\u2013450","journal-title":"Am J Clin Pathol"},{"key":"6721_CR10","first-page":"2","volume":"38","author":"KN Moorani","year":"2022","unstructured":"Moorani KN, Aziz M, Amanullah F (2022) Rapidly progressive glomerulonephritis in children. Pak J Med Sci 38:2","journal-title":"Pak J Med Sci"},{"key":"6721_CR11","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.autrev.2013.06.014","volume":"12","author":"F Dammacco","year":"2013","unstructured":"Dammacco F, Battaglia S, Gesualdo L, Racanelli V (2013) Goodpasture\u2019s disease: a report of ten cases and a review of the literature. Autoimmun Rev 12:1101\u20131108","journal-title":"Autoimmun Rev"},{"key":"6721_CR12","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/j.ajkd.2008.10.005","volume":"53","author":"AJ Collins","year":"2009","unstructured":"Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, Kasiske B, Liu J, Mau LW, McBean M, Murray A, St Peter W, Guo H, Li Q, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L (2009) United States Renal Data System 2008 annual data report. Am J Kidney Dis 53:S1\u2013S374","journal-title":"Am J Kidney Dis"},{"key":"6721_CR13","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.3390\/jcm9082385","volume":"9","author":"JG Maliakkal","year":"2020","unstructured":"Maliakkal JG, Hicks MJ, Michael M, Selewski DT, Twombley K, Rheault MN, Seamon M, Misurac JM, Tran CL, Reyes L, Flynn JT, Onder AM, Constantinescu AR, Singh V, Pan C, Omoloja A, Wu Q, Smoyer WE, Hidalgo G, Wenderfer SE (2020) Renal survival in children with glomerulonephritis with crescents: a pediatric nephrology research consortium cohort study. J Clin Med 9:2385","journal-title":"J Clin Med"},{"key":"6721_CR14","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1111\/j.1523-1755.2004.00917.x","volume":"66","author":"JB Levy","year":"2004","unstructured":"Levy JB, Hammad T, Coulthart A, Dougan T, Pusey CD (2004) Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int 66:2535\u20132540","journal-title":"Kidney Int"},{"key":"6721_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1053\/j.ajkd.2005.05.003","volume":"46","author":"A Rutgers","year":"2005","unstructured":"Rutgers A, Slot M, van Paassen P, van Breda VP, Heeninga P, Tervaert JWC (2005) Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentis gomerulonephritis. Am J Kidney Dis 46:253\u2013262","journal-title":"Am J Kidney Dis"},{"key":"6721_CR16","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1744-9987.2009.00724.x","volume":"13","author":"J Lindi\u010d","year":"2009","unstructured":"Lindi\u010d J, Vizjak A, Ferluga D, Kova\u010d D, Ale\u0161 A, Kveder R, Ponikvar R, Bren A (2009) Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane. Ther Apher Dial 13:278\u2013281","journal-title":"Ther Apher Dial"},{"key":"6721_CR17","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/MNH.0b013e328344ff20","volume":"20","author":"V Pedchenko","year":"2011","unstructured":"Pedchenko V, Vanacore R, Hudson B (2011) Goodpasture\u2019s disease: molecular architecture of the autoantigen provides clues to etiology and pathogenesis. Curr Opin Nephrol Hypertens 20:290\u2013296","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"6721_CR18","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/j.1440-1797.2011.01484.x","volume":"16","author":"J de Zoysa","year":"2011","unstructured":"de Zoysa J, Taylor D, Thein H, Yehia M (2011) Incidence and features of dual anti-GBM positive and ANCA-positive patients. Nephrology 16:725\u2013729","journal-title":"Nephrology"},{"key":"6721_CR19","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s10067-012-2062-9","volume":"31","author":"A Bayat","year":"2012","unstructured":"Bayat A, Kamperis K, Herlin T (2012) Characteristics and outcome of Goodpasture\u2019s disease in children. Clin Rheumatol 31:1745\u20131751","journal-title":"Clin Rheumatol"},{"key":"6721_CR20","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00467-004-1762-z","volume":"20","author":"MM Hijosa","year":"2005","unstructured":"Hijosa MM, Rom\u00e1n LE, Camblor CF, Garc\u00eda ML, Salcedo DP, Torres MN (2005) Anti-GBM and anti-MPO antibodies coexist in a case of pulmonary renal syndrome. Pediatr Nephrol 20:807\u2013810","journal-title":"Pediatr Nephrol"},{"key":"6721_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00467-008-0928-5","volume":"24","author":"S Naidoo","year":"2009","unstructured":"Naidoo S, Waller S (2009) Anti-GBM antibodies co-exist with MPO-ANCA in a 4-year-old girl with acute renal failure. Pediatr Nephrol 24:215\u2013216","journal-title":"Pediatr Nephrol"},{"key":"6721_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00467-010-1663-2","volume":"26","author":"SR Williamson","year":"2011","unstructured":"Williamson SR, Phillips CL, Andreoli SP, Nailescu C (2011) A 25-year experience with pediatric anti-glomerular basement membrane disease. Pediatr Nephrol 26:85\u201391","journal-title":"Pediatr Nephrol"},{"key":"6721_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1471-2369-14-66","volume":"14","author":"R Bogdanovi\u0107","year":"2013","unstructured":"Bogdanovi\u0107 R, Mini\u0107 P, Markovi\u0107-Lipkovski J, Staji\u0107 N, Savi\u0107 N, Rodi\u0107 M (2013) Pulmonary renal syndrome in a child with coexistence of anti-neutrophil cytoplasmic antibodies and anti-glomerular basement membrane disease: case report and literature review. BMC Nephrol 14:66","journal-title":"BMC Nephrol"},{"key":"6721_CR24","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s10067-013-2268-5","volume":"32","author":"A Srivastava","year":"2013","unstructured":"Srivastava A, Rao GK, Segal PE, Shah M, Geetha D (2013) Characteristics and outcome of crescentic glomerulonephritis in patients with both antineutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody. Clin Rheumatol 32:1317\u20131322","journal-title":"Clin Rheumatol"},{"key":"6721_CR25","doi-asserted-by":"publisher","first-page":"991469","DOI":"10.3389\/fimmu.2022.991469","volume":"13","author":"X Hu","year":"2022","unstructured":"Hu X, Shen C, Meng T, Ooi JD, Eggenhuizen PJ, Zhou YO, Luo H, Chen JB, Lin W, Gong Y, Xiong Q, Xu J, Liu N, Xiao X, Tang R, Zhong Y (2022) Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients. Front Immunol 13:991469","journal-title":"Front Immunol"},{"key":"6721_CR26","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1093\/ndt\/gfh448","volume":"19","author":"N Gittins","year":"2004","unstructured":"Gittins N, Basu A, Eyre J, Gholkar A, Moghal N (2004) Cerebral vasculitis in a teenager with Goodpasture\u2019s syndrome. Nephrol Dial Transplant 19:3168\u20133171","journal-title":"Nephrol Dial Transplant"},{"key":"6721_CR27","doi-asserted-by":"publisher","first-page":"220208","DOI":"10.1183\/20734735.0208-2022","volume":"18","author":"N Boyle","year":"2022","unstructured":"Boyle N, O\u2019Callaghan M, Ataya A, Gupta N, Keane MP, Murphy DJ, McCarthy C (2022) Pulmonary renal syndrome: a clinical review. Breathe 18:220208","journal-title":"Breathe"},{"key":"6721_CR28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.32074\/1591-951X-990","volume":"116","author":"V L\u2019Imperio","year":"2024","unstructured":"L\u2019Imperio V, Ceola S, Cerbelli B, Barreca A, Pagni F (2024) Systemic vasculitis involving the kidney: the nephropathologist\u2019s point of view. Pathologica 116:104\u2013118","journal-title":"Pathologica"},{"key":"6721_CR29","doi-asserted-by":"publisher","first-page":"108325","DOI":"10.1016\/j.clim.2019.108325","volume":"211","author":"M Jariwala","year":"2020","unstructured":"Jariwala M, Laxer RM (2020) Childhood GPA, EGPA, and MPA. Clin Immunol 211:108325","journal-title":"Clin Immunol"},{"key":"6721_CR30","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.2215\/CJN.13591215","volume":"11","author":"M Canney","year":"2016","unstructured":"Canney M, O\u2019Hara PV, McEvoy CM, Medani S, Connaughton DM, Abdalla AA, Doyle R, Stack AG, O\u2019Seaghdha CM, Clarkson MR, Griffin MD, Holian J, Dorman AM, Niland A, Keogan M, Wallace EM, Conlon NP, Walsh C, Kelly A, Little MA (2016) Spatial and temporal clustering of anti-glomerular basement membrane disease. Clin J Am Soc Nephrol 11:1392\u20131399","journal-title":"Clin J Am Soc Nephrol"},{"key":"6721_CR31","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.kint.2020.06.009","volume":"98","author":"M Prendecki","year":"2020","unstructured":"Prendecki M, Clarke C, Cairns T, Cook T, Roufosse C, Thomas D, Willicombe M, Pusey CD, McAdoo SP (2020) Anti-glomerular basement membrane disease during the COVID-19 pandemic. Kidney Int 98:780\u2013781","journal-title":"Kidney Int"},{"key":"6721_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12882-021-02275-4","volume":"22","author":"A Winkler","year":"2021","unstructured":"Winkler A, Zitt E, Sprenger-M\u00e4hr H, Soleiman A, Cejna M, Lhotta K (2021) SARS-CoV-2 infection and recurrence of anti-glomerular basement disease: a case report. BMC Nephrol 22:75","journal-title":"BMC Nephrol"},{"key":"6721_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00467-004-1645-3","volume":"20","author":"K Kano","year":"2005","unstructured":"Kano K, Yamada Y, Sato Y, Arisaka O, Ono Y, Ueda Y (2005) Glomerulonephritis in a patient with chronic active Epstein-Barr virus infection. Pediatr Nephrol 20:89\u201392","journal-title":"Pediatr Nephrol"},{"key":"6721_CR34","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.2215\/CJN.01060307","volume":"2","author":"M Waldman","year":"2007","unstructured":"Waldman M, Kopp JB (2007) Parvovirus B19 and the kidney. Clin J Am Soc Nephrol 2:S47\u2013S56","journal-title":"Clin J Am Soc Nephrol"},{"key":"6721_CR35","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00467-019-04436-y","volume":"35","author":"U Mayer","year":"2020","unstructured":"Mayer U, Schmitz J, Brasen JH, Pape L (2020) Crescentic glomerulonephritis in children. Pediatr Nephrol 35:829\u2013842","journal-title":"Pediatr Nephrol"},{"key":"6721_CR36","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.ekir.2023.03.010","volume":"8","author":"J Bharati","year":"2023","unstructured":"Bharati J, Yang Y, Sharma P, Jhaveri KD (2023) Atypical anti-glomerular basement membrane disease. Kidney Int Rep 8:1151\u20131161","journal-title":"Kidney Int Rep"},{"key":"6721_CR37","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.2215\/CJN.01210214","volume":"9","author":"DG Noone","year":"2014","unstructured":"Noone DG, Twilt M, Hayes WN, Thorner PS, Benseler S, Laxer RM, Parekh RS, Hebert D (2014) The new histopathologic classification of ANCA-associated GN and its association with renal outcomes in childhood. Clin J Am Soc Nephrol 9:1684\u20131691","journal-title":"Clin J Am Soc Nephrol"},{"key":"6721_CR38","doi-asserted-by":"crossref","unstructured":"Morishita KA, Moorthy LN, Lubieniecka JM, Twilt M, Yeung RSM, Toth MB, Shenoi S, Ristic G, Nielsen SM, Luqmani RA, Li SC, Lee T, Lawson EF, Kostik MM, Klein-Gitelman M, Huber AM, Hersh AO, Foell D, Elder ME, Eberhard BA, Dancey P, Charuvanij S, Benseler SM, Cabral DA; ARChiVe Investigators Network within the PedVas Initiative (2017) Early outcomes in children with antineutrophil cytoplasmic antibody\u2013associated vasculitis. Arthritis Rheumatol 69:1470-1479","DOI":"10.1002\/art.40112"},{"key":"6721_CR39","doi-asserted-by":"publisher","first-page":"c59","DOI":"10.1159\/000072022","volume":"94","author":"M Segelmark","year":"2003","unstructured":"Segelmark M, Hellmark T, Wieslander J (2003) The prognostic significance in Goodpasture\u2019s disease of specificity, titre and affinity of anti-glomerular-basement-membrane antibodies. Nephron Clin Pract 94:c59\u2013c68","journal-title":"Nephron Clin Pract"},{"key":"6721_CR40","first-page":"107","volume":"36","author":"X Bosch","year":"1991","unstructured":"Bosch X, Mirapeix E, Font J, Borrellas X, Rodr\u00edguez R, L\u00f3pez-Soto A, Ingelmo M, Revert L (1991) Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. Clin Nephrol 36:107\u2013113","journal-title":"Clin Nephrol"},{"key":"6721_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/0886022X.2020.1854301","volume":"43","author":"Z Zahir","year":"2021","unstructured":"Zahir Z, Wani AS, Prasad N, Jain M (2021) Clinicopathological characteristics and predictors of poor outcome in antiglomerular basement membrane disease \u2013 a fifteen year single center experience. Ren Fail 43:79\u201389","journal-title":"Ren Fail"},{"key":"6721_CR42","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.kint.2018.07.020","volume":"94","author":"SR Brix","year":"2018","unstructured":"Brix SR, Noriega M, Tennstedt P, Vettorazzi E, Busch M, Nitschke M, Jabs WJ, \u00d6zcan F, Wendt R, Hausberg M, Sellin L, Panzer U, Huber TB, Waldherr R, Hopfer H, Stahl RAK, Wiech T (2018) Development and validation of a renal risk score in ANCA-associated glomerulonephritis. Kidney Int 94:1177\u20131188","journal-title":"Kidney Int"},{"key":"6721_CR43","doi-asserted-by":"publisher","first-page":"5278","DOI":"10.3390\/ijms25105278","volume":"25","author":"E Fouka","year":"2024","unstructured":"Fouka E, Drakopanagiotakis F, Steiropoulos P (2024) Pathogenesis of pulmonary manifestations in ANCA-associated vasculitis and Goodpasture syndrome. Int J Mol Sci 25:5278","journal-title":"Int J Mol Sci"},{"key":"6721_CR44","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1503\/cmaj.081117","volume":"180","author":"EC Goligher","year":"2009","unstructured":"Goligher EC, Detsky AS (2009) Migratory pulmonary infiltrates. Goodpasture syndrome Can Med Assoc J 180:75\u201377","journal-title":"Goodpasture syndrome Can Med Assoc J"},{"key":"6721_CR45","first-page":"964","volume":"41","author":"F Reggiani","year":"2023","unstructured":"Reggiani F, L\u2019Imperio V, Calatroni M, Pagni F, Sinico RA (2023) Goodpasture syndrome and anti-glomerular basement membrane disease. Clin Exp Rheumatol 41:964\u2013974","journal-title":"Clin Exp Rheumatol"},{"key":"6721_CR46","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1136\/thorax.55.6.502","volume":"55","author":"MI Schwarz","year":"2000","unstructured":"Schwarz MI, Brown KK (2000) Small vessel vasculitis of the lung. Thorax 55:502\u2013510","journal-title":"Thorax"},{"key":"6721_CR47","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1111\/j.1523-1755.2004.00917.x","volume":"66","author":"JB Levy","year":"2004","unstructured":"Levy JB, Hammad T, Coulthart A, Dougan T, Pusey CD (2004) Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int 66:1535\u20131540","journal-title":"Kidney Int"},{"key":"6721_CR48","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1111\/ijd.16247","volume":"61","author":"LE Gibson","year":"2022","unstructured":"Gibson LE (2022) Cutaneous manifestations of antineutrophil cytoplasmic antibody-associated vasculitis (AAV): a concise review with emphasis on clinical and histopathologic correlation. Int J Dermatol 61:1442\u20131451","journal-title":"Int J Dermatol"},{"key":"6721_CR49","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.carj.2016.08.005","volume":"68","author":"J Shankar","year":"2017","unstructured":"Shankar J, Banfield J (2017) Posterior reversible encephalopathy syndrome: a review. Can Assoc Radiol J 68:147\u2013153","journal-title":"Can Assoc Radiol J"},{"key":"6721_CR50","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s13730-020-00473-x","volume":"9","author":"S Tsuneyoshi","year":"2020","unstructured":"Tsuneyoshi S, Yamada S, Matsumoto H, Yamaguchi S, Wakisaka K, Ueki K, Fujisaki K, Ago T, Nakano T, Kitazono T (2020) Anti-glomerular basement membrane disease complicated with posterior reversible encephalopathy syndrome and subcortical cerebral hemorrhage: a case report and review of the literature. CEN Case Rep 9:278\u2013284","journal-title":"CEN Case Rep"},{"key":"6721_CR51","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/24725625.2020.1816640","volume":"5","author":"Y Taniguchi","year":"2021","unstructured":"Taniguchi Y, Hanaoka R (2021) Anti-glomerular basement membrane antibody disease complicated by posterior reversible encephalopathy syndrome. Mod Rheumatol Case Rep 5:162\u2013166","journal-title":"Mod Rheumatol Case Rep"},{"key":"6721_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1074","volume":"11","author":"C Han","year":"2023","unstructured":"Han C, Cui X, Tan Z, Li Y, Qiao Y (2023) Antiglomerular basement membrane antibody type rapidly progressive glomerulonephritis with seizures: two cases and literature review. Immun Inflamm Dis 11:e1074","journal-title":"Immun Inflamm Dis"},{"key":"6721_CR53","first-page":"321","volume":"336","author":"F Holguin","year":"2008","unstructured":"Holguin F, Ramadan B, Gal AA, Roman J (2008) Prognostic factors for hospital mortality and ICU admission in patients with ANCA-related pulmonary vasculitis. Arthritis Rheumatol 336:321\u2013326","journal-title":"Arthritis Rheumatol"},{"key":"6721_CR54","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/rheumatology\/keg322","volume":"42","author":"BA Cruz","year":"2003","unstructured":"Cruz BA, Ramanoelina J, Mahr A, Cohen P, Mouthon L, Cohen Y, Hoang P, Guillevin L (2003) Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unit. Rheumatology (Oxford) 42:1183\u20131188","journal-title":"Rheumatology (Oxford)"},{"key":"6721_CR55","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0140-6736(23)01736-1","volume":"403","author":"A Kronbichler","year":"2024","unstructured":"Kronbichler A, Bajema IM, Bruchfeld A, Mastroianni Kirsztajn G, Stone JH (2024) Diagnosis and management of ANCA-associated vasculitis. Lancet 403:683\u2013698","journal-title":"Lancet"},{"key":"6721_CR56","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group (2021) KDIGO 2021 Clinical practice guideline for the management of glomerular diseases. Kidney Int 100:S1\u2013S276","journal-title":"Kidney Int"},{"key":"6721_CR57","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/rheumatology\/key322","volume":"58","author":"N de Graeff","year":"2019","unstructured":"de Graeff N, Groot N, Brogan P, Ozen S, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, Marks SD, McCann L, Pilkington C, Ravelli A, van Royen A, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Beresford MW (2019) European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides\u2013the SHARE initiative. Rheumatology 58:656\u2013671","journal-title":"Rheumatology"},{"key":"6721_CR58","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3390\/ijms20020444","volume":"20","author":"G Ferrara","year":"2019","unstructured":"Ferrara G, Petrillo MG, Giani T, Marrani E, Filippeschi C, Oranges T, Simonini G, Cimaz R (2019) Clinical use and molecular action of corticosteroids in the pediatric age. Int J Mol Sci 20:444","journal-title":"Int J Mol Sci"},{"key":"6721_CR59","doi-asserted-by":"publisher","first-page":"m421","DOI":"10.1136\/bmj.m421","volume":"368","author":"ZS Wallace","year":"2020","unstructured":"Wallace ZS, Miloslavsky EM (2020) Management of ANCA associated vasculitis. BMJ 368:m421","journal-title":"BMJ"},{"key":"6721_CR60","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/ckj\/sfv008","volume":"8","author":"GH Greenhall","year":"2015","unstructured":"Greenhall GH, Salama AD (2015) What is new in the management of rapidly progressive glomerulonephritis? Clin Kidney J 8:143\u2013150","journal-title":"Clin Kidney J"},{"key":"6721_CR61","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U; RAVE-ITN Research Group","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U; RAVE-ITN Research Group (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363:221\u2013232","journal-title":"N Engl J Med"},{"key":"6721_CR62","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/jca.20240","volume":"25","author":"Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH; Apheresis Applications Committee of the American Society for Apheresis","year":"2010","unstructured":"Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH; Apheresis Applications Committee of the American Society for Apheresis (2010) Guidelines on the use of therapeutic apheresis in clinical practice\u2013evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 25:83\u2013177","journal-title":"J Clin Apher"},{"key":"6721_CR63","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/kisup.2012.30","volume":"2","author":"KU Eckardt","year":"2012","unstructured":"Eckardt KU, Kasiske BL (2012) KDIGO clinical practice guideline for glomerulonephritis. Kidney Int 2:259\u2013264","journal-title":"Kidney Int"},{"key":"6721_CR64","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1053\/j.ajkd.2010.10.049","volume":"57","author":"M Walsh","year":"2011","unstructured":"Walsh M, Catapano F, Szpirt W, Thorlund K, Bruchfeld A, Guillevin L, Haubitz M, Merkel PA, Peh CA, Pusey C, Jayne D (2011) Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis. Am J Kidney Dis 57:566\u2013574","journal-title":"Am J Kidney Dis"},{"key":"6721_CR65","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1681\/ASN.2007010090","volume":"18","author":"Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, Mirapeix E, Savage CO, Sinico RA, Stegeman CA, Westman KW, van der Woude FJ, de Lind van Wijngaarden RA, Pusey CD; European Vasculitis Study Group","year":"2007","unstructured":"Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, Mirapeix E, Savage CO, Sinico RA, Stegeman CA, Westman KW, van der Woude FJ, de Lind van Wijngaarden RA, Pusey CD; European Vasculitis Study Group (2007) Randomized trial of plasma exchange or high dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18:2180\u20132188","journal-title":"J Am Soc Nephrol"},{"key":"6721_CR66","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1056\/NEJMoa1803537","volume":"382","author":"M Walsh","year":"2020","unstructured":"Walsh M, Merkel PA, Peh CA, Szpirt WM, Pu\u00e9chal X, Fujimoto S, Hawley CM, Khalidi N, Flo\u00dfmann O, Wald R, Girard LP, Levin A, Gregorini G, Harper L, Clark WF, Pagnoux C, Specks U, Smyth L, Tesar V, Ito-Ihara T, de Zoysa JR, Szczeklik W, Flores-Su\u00e1rez LF, Carette S, Guillevin L, Pusey CD, Casian AL, Brezina B, Mazzetti A, McAlear CA, Broadhurst E, Reidlinger D, Mehta S, Ives N, Jayne DRW; PEXIVAS Investigators (2020) Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Engl J Med 382:622\u2013631","journal-title":"N Engl J Med"},{"key":"6721_CR67","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1053\/j.ajkd.2003.08.015","volume":"42","author":"PJ Klemmer","year":"2003","unstructured":"Klemmer PJ, Chalermskulrat W, Reif MS, Hogan SL, Henke DC, Falk RJ (2003) Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis 42:1149\u20131153","journal-title":"Am J Kidney Dis"},{"key":"6721_CR68","doi-asserted-by":"publisher","first-page":"e103568","DOI":"10.1371\/journal.pone.0103568","volume":"9","author":"P Biesenbach","year":"2014","unstructured":"Biesenbach P, Kain R, Derfler K, Perkmann T, Soleiman A, Benharkou A, Druml W, Rees A, S\u00e4emann MD (2014) Long-term outcome of anti-glomerular basement membrane antibody disease treated with immunoadsorption. PLoS One 9:e103568","journal-title":"PLoS ONE"},{"key":"6721_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2369-15-128","volume":"15","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Tang Z, Chen D, Gong D, Ji D, Liu Z (2014) Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis. BMC Nephrol 15:128","journal-title":"BMC Nephrol"},{"key":"6721_CR70","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.ekir.2018.12.002","volume":"4","author":"R Jain","year":"2018","unstructured":"Jain R, Dgheim H, Bomback AS (2018) Rituximab for anti\u2013glomerular basement membrane disease. Kidney Int Rep 4:614\u2013618","journal-title":"Kidney Int Rep"},{"key":"6721_CR71","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1136\/annrheumdis-2014-206404","volume":"74","author":"Jones RB, Furuta S, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh M, Westman K, Jayne DR; European Vasculitis Society (EUVAS)","year":"2015","unstructured":"Jones RB, Furuta S, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh M, Westman K, Jayne DR; European Vasculitis Society (EUVAS) (2015) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial. Ann Rheum Dis 74:1178\u20131182","journal-title":"Ann Rheum Dis"},{"key":"6721_CR72","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1681\/ASN.2021111460","volume":"33","author":"F Uhlin","year":"2022","unstructured":"Uhlin F, Szpirt W, Kronbichler A, Bruchfeld A, Soveri I, Rostaing L, Daugas E, Lionet A, Kamar N, Rafat C, Myslive\u010dek M, Tesa\u0159 V, Fernstr\u00f6m A, Kjellman C, Elfving C, McAdoo S, M\u00f6lne J, Bajema I, Sonesson E, Segelmark M (2022) Endopeptidase cleavage of anti-glomerular basement membrane antibodies in vivo in severe kidney disease: an open-label phase 2a study. J Am Soc Nephrol 33:829\u2013838","journal-title":"J Am Soc Nephrol"},{"key":"6721_CR73","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.kint.2019.06.019","volume":"96","author":"I Soveri","year":"2019","unstructured":"Soveri I, M\u00f6lne J, Uhlin F, Nilsson T, Kjellman C, Sonesson E, Segelmark M (2019) The IgG-degrading enzyme of Streptococcus pyogenes causes rapid clearance of anti-glomerular basement membrane antibodies in patients with refractory anti-glomerular basement membrane disease. Kidney Int 96:1234\u20131238","journal-title":"Kidney Int"},{"key":"6721_CR74","unstructured":"National Institutes of Health (n.d.) A study with imlifidase in anti-GBM disease (GOOD-IDES-02). https:\/\/clinicaltrials.gov\/study\/NCT05679401"},{"key":"6721_CR75","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1681\/ASN.2016111179","volume":"28","author":"Jayne DRW, Bruchfeld AN, Harper L, Schaier M, Venning MC, Hamilton P, Burst V, Grundmann F, Jadoul M, Szombati I, Tesa\u0159 V, Segelmark M, Potarca A, Schall TJ, Bekker P; CLEAR Study Group","year":"2017","unstructured":"Jayne DRW, Bruchfeld AN, Harper L, Schaier M, Venning MC, Hamilton P, Burst V, Grundmann F, Jadoul M, Szombati I, Tesa\u0159 V, Segelmark M, Potarca A, Schall TJ, Bekker P; CLEAR Study Group (2017) Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis. J Am Soc Nephrol 28:2756\u20132767","journal-title":"J Am Soc Nephrol"},{"key":"6721_CR76","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.ekir.2023.01.039","volume":"8","author":"Cortazar FB, Niles JL, Jayne DRW, Merkel PA, Bruchfeld A, Yue H, Schall TJ, Bekker P; ADVOCATE Study Group","year":"2023","unstructured":"Cortazar FB, Niles JL, Jayne DRW, Merkel PA, Bruchfeld A, Yue H, Schall TJ, Bekker P; ADVOCATE Study Group (2023) Renal recovery for patients with ANCA-associated vasculitis and low eGFR in the ADVOCATE trial of avacopan. Kidney Int Rep 8:860\u2013870","journal-title":"Kidney Int Rep"},{"key":"6721_CR77","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.ekir.2024.03.022","volume":"9","author":"R Zonozi","year":"2024","unstructured":"Zonozi R, Aqeel F, Le D, Cortazar FB, Thaker J, Zabala Ramirez MJ, Sattui Cortes SE, Attieh RM, Chung M, Bulbin DH, Shaikh A, Guaman K, Ford J, Diffie C, Gewurz-Singer O, Sauvage G, Jeyabalan A, Geara A, Ayoub I, Bomback A, Khoury LL, George JC, Jhaveri KD, Derebail VK, Niles JL, Geetha D (2024) Real-world experience with avacopan in antineutrophil cytoplasmic autoantibody-associated vasculitis. Kidney Int Rep 9:1783\u20131791","journal-title":"Kidney Int Rep"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06721-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-025-06721-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06721-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T11:04:12Z","timestamp":1750763052000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-025-06721-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":77,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["6721"],"URL":"https:\/\/doi.org\/10.1007\/s00467-025-06721-5","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"assertion":[{"value":"24 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the child\u2019s mother for the publication of this manuscript and any accompanying images or figures related to this case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}